SANACENTER
ActiveSummary
SANACENTER has been active since 1983 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €72,707 and a net result of €1,987. Equity is growing by ~5.5% per year across the filed fiscal years. Its solvency ranks better than 45% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability71▼-4
Solvency82▲+5
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5,000 at 30 days acceptable
Liquidity ample (current ratio 2.28 against 2.24 in 2024; short-term debt: 19.3% and cash: 10.5% of total assets), and 42.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
57.3%
Return on assets
1.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-06-2026, 60 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
60 d early
2024
84 d early
2023
56 d early
2022
81 d early
2021
76 d early
2020
59 d early
2019
65 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 69 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 16 May (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€72,707▲ 2.8%
2024 · €70,720
Total assets
€126,922▼ 6.5%
2024 · €135,737
Net result
€1,987▼ 68.8%
2024 · €6,365
Working capital
€31,453▲ 11.4%
2024 · €28,226
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€23,606▲ 325%-€331€9,812€14,141▲ 44.1%€7,071▼ 50.0%
Net result€15,267below the sector's middle half-€5,761below the sector's middle half€2,937below the sector's middle half€6,365below the sector's middle half▲ 117%€1,987below the sector's middle half▼ 68.8%
Equity€67,178within the sector's middle half▲ 29.4%€61,417within the sector's middle half▼ 8.6%€64,355within the sector's middle half▲ 4.8%€70,720within the sector's middle half▲ 9.9%€72,707within the sector's middle half▲ 2.8%
Total assets€175,010within the sector's middle half▲ 10.5%€153,092within the sector's middle half▼ 12.5%€151,770within the sector's middle half▼ 0.9%€135,737within the sector's middle half▼ 10.6%€126,922within the sector's middle half▼ 6.5%
Debt€107,832▲ 1.2%€91,675▼ 15.0%€87,415▼ 4.6%€65,016▼ 25.6%€54,215▼ 16.6%
Working capital€22,080below the sector's middle half▼ 20.3%€14,111below the sector's middle half▼ 36.1%€24,934within the sector's middle half▲ 76.7%€28,226within the sector's middle half▲ 13.2%€31,453within the sector's middle half▲ 11.4%
Solvency38.4%within the sector's middle half▲ 5.6pp40.1%within the sector's middle half▲ 1.7pp42.4%within the sector's middle half▲ 2.3pp52.1%within the sector's middle half▲ 9.7pp57.3%within the sector's middle half▲ 5.2pp
Current ratio2.08within the sector's middle half▼ 0.341.54within the sector's middle half▼ 0.541.84within the sector's middle half▲ 0.302.24within the sector's middle half▲ 0.402.28within the sector's middle half▲ 0.04
Return on assets (ROA)8.7%within the sector's middle half▲ 8.9pp-3.8%below the sector's middle half▼ 12.5pp1.9%below the sector's middle half▲ 5.7pp4.7%below the sector's middle half▲ 2.8pp1.6%below the sector's middle half▼ 3.1pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 50% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €126,922
Fixed assets
€70,941 ▼ 16.3%
Current assets
€55,980 ▲ 9.9%
Equity and liabilities €126,922
Equity
€72,707 ▲ 2.8%
Debt
€54,215 ▼ 16.6%
Debt's share of the balance-sheet total falls from 47.9% to 42.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€33,978▼
2024 · €39,880
Cash flow
€28,894▼
2024 · €32,105
Debt to equity
0.75▼
2024 · 0.92
ROE
2.7%▼
2024 · 9.0%
Interest coverage
11.50▲
2024 · 11.01
Debt ≤ 1 year
€24,528▲
2024 · €22,718
Debt > 1 year
€29,687▼
2024 · €42,298
Income taxes
€2,298▼
2024 · €4,304
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,027 companies that looked in July 2024 the way this one looks now, 0.5% went bankrupt within 24 months and 94% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit under 5% of the balance sheet
0.5%
went bankrupt
4.9%
stopped otherwise
94%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,027 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | €6,401 | €0 | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €16,652 | €22,596 | €24,104 | €25,739 | €26,907 | ▲ 4.5% |
| Other operating charges640/8 | €2,976 | €3,050 | €3,327 | €2,847 | €2,646 | ▼ 7.1% |
| Non-recurring operating charges66A | - | - | €3,072 | €0 | - | - |
| Gross operating margin9900 | €43,234 | €25,315 | €40,315 | €42,727 | €36,624 | ▼ 14.3% |
| Operating profit (loss)9901 | €23,606 | -€331 | €9,812 | €14,141 | €7,071 | ▼ 50.0% |
| Financial income75/76B | €0 | €1 | €0 | €152 | €169 | ▲ 11.1% |
| Recurring financial income75 | €0 | €1 | €0 | €152 | €169 | ▲ 11.1% |
| Financial charges65/66B | €5,540 | €4,816 | €4,147 | €3,623 | €2,955 | ▼ 18.4% |
| Recurring financial charges65 | €5,540 | €4,816 | €4,147 | €3,623 | €2,955 | ▼ 18.4% |
| Profit (loss) for the period before taxes9903 | €18,067 | -€5,147 | €5,665 | €10,670 | €4,285 | ▼ 59.8% |
| Income taxes67/77 | €2,800 | €614 | €2,728 | €4,304 | €2,298 | ▼ 46.6% |
| Profit (loss) for the period9904 | €15,267 | -€5,761 | €2,937 | €6,365 | €1,987 | ▼ 68.8% |
| Profit (loss) for the period to be appropriated9905 | €15,267 | -€5,761 | €2,937 | €6,365 | €1,987 | ▼ 68.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €175,010 | €153,092 | €151,770 | €135,737 | €126,922 | ▼ 6.5% |
| Fixed assets21/28 | €132,535 | €112,939 | €97,201 | €84,793 | €70,941 | ▼ 16.3% |
| Tangible fixed assets22/27 | €132,535 | €112,939 | €97,201 | €84,793 | €70,941 | ▼ 16.3% |
| Land and buildings22 | €90,386 | €76,754 | €65,994 | €63,033 | €55,354 | ▼ 12.2% |
| Plant, machinery and equipment23 | €2,471 | €4,693 | €7,154 | €5,055 | €7,785 | ▲ 54.0% |
| Furniture and vehicles24 | €39,678 | €31,492 | €24,053 | €16,705 | €7,802 | ▼ 53.3% |
| Leasing and similar rights25 | €0 | - | - | - | - | - |
| Current assets29/58 | €42,475 | €40,154 | €54,569 | €50,944 | €55,980 | ▲ 9.9% |
| Amounts receivable within one year40/41 | €3,130 | €2,700 | €11,321 | €3,359 | €1,443 | ▼ 57.0% |
| Trade receivables40 | €1,443 | €1,443 | €1,443 | €1,443 | €1,443 | = |
| Other amounts receivable41 | €1,687 | €1,257 | €9,878 | €1,916 | €0 | ▼ 100% |
| Current investments50/53 | €30,038 | €30,038 | €30,038 | €30,184 | €40,302 | ▲ 33.5% |
| Cash at bank and in hand54/58 | €6,642 | €4,864 | €11,446 | €16,630 | €13,378 | ▼ 19.6% |
| Deferred charges and accrued income490/1 | €2,664 | €2,551 | €1,763 | €770 | €857 | ▲ 11.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €175,010 | €153,092 | €151,770 | €135,737 | €126,922 | ▼ 6.5% |
| Equity10/15 | €67,178 | €61,417 | €64,355 | €70,720 | €72,707 | ▲ 2.8% |
| Contributions10/11 | €43,600 | €43,600 | €43,600 | €43,600 | €43,600 | = |
| Reserves13 | €4,360 | €4,360 | €4,360 | €10,725 | €10,725 | = |
| Non-distributable reserves130/1 | €4,360 | €4,360 | €0 | - | - | - |
| Reserves not available under the articles1311 | €4,360 | €4,360 | €0 | - | - | - |
| Distributable reserves133 | - | - | €4,360 | €10,725 | €10,725 | = |
| Profit (loss) carried forward14 | €19,218 | €13,457 | €16,395 | €16,395 | €18,382 | ▲ 12.1% |
| Amounts payable17/49 | €107,832 | €91,675 | €87,415 | €65,016 | €54,215 | ▼ 16.6% |
| Amounts payable after more than one year17 | €87,437 | €65,632 | €57,780 | €42,298 | €29,687 | ▼ 29.8% |
| Financial debts170/4 | €87,437 | €65,632 | €57,780 | €42,298 | €29,687 | ▼ 29.8% |
| Amounts payable within one year42/48 | €20,395 | €26,043 | €29,635 | €22,718 | €24,528 | ▲ 8.0% |
| Current portion of amounts payable after more than one year42 | €14,289 | €21,805 | €15,143 | €15,482 | €12,611 | ▼ 18.5% |
| Trade debts44 | €3,306 | €3,638 | €5,021 | €3,000 | €3,582 | ▲ 19.4% |
| Suppliers440/4 | €3,306 | €3,638 | €5,021 | €3,000 | €3,582 | ▲ 19.4% |
| Taxes, remuneration and social security45 | €2,800 | €600 | €2,700 | €4,237 | €6,484 | ▲ 53.0% |
| Taxes450/3 | €2,800 | €600 | €2,700 | €4,237 | €6,484 | ▲ 53.0% |
| Other amounts payable47/48 | €0 | - | €6,771 | €0 | €1,851 | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €15,267 | -€5,761 | €2,937 | €6,365 | €1,987 | ▼ 68.8% |
| + Depreciation and write-downs630 | €16,652 | €22,596 | €24,104 | €25,739 | €26,907 | ▲ 4.5% |
| Operating cash flow (approximation) | €31,919 | €16,835 | €27,041 | €32,105 | €28,894 | ▼ 10.0% |
| Investment in fixed assets (approximation) | - | -€3,000 | -€8,366 | -€13,331 | -€13,056 | ▲ 2.1% |
| Change in cash | - | -€1,779 | €6,582 | €5,184 | -€3,253 | ▼ 163% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
01-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
08-05
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
05-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Back to profitnet €2,937
Net result €2,937 after one loss-making year.
11-05
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet -€5,761
Net result drops to -€5,761, the lowest in the series; recovery starts the following year.
16-05
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Back to profitnet €15,267
Net result €15,267 after 3 loss-making years.
02-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
27-05
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
17-05
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
22-05
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
09-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beveren-Kruibeke-Zwijndrecht · 1 establishment unit since 2003
Ground area
453 m²
Building footprint
205 m²
Volume, LiDAR
1,463 m³
Parcel 11056A0407/00A002, Flanders · tallest building 10.4 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
SANACENTER
since 20032.301.927.289
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11056A0407/00A002 | Flanders | 453 m² | 1 · 205 m² | 10.3 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 4 entries · 3,315 EUR awarded · 3,258 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 567 EUR | 567 EUR |
| 2024 | 1 | 1,062 EUR | 1,062 EUR |
| 2023 | 1 | 828 EUR | 771 EUR |
| 2022 | 1 | 858 EUR | 858 EUR |
Similar companies · same sector, comparable size
Kinesitherapie Lynn Beunnens
BE 1004.016.118
Kapelle-op-den-Bos · Eq €72,726
MARINE DENIS
BE 0802.708.157
Welkenraedt · Eq €72,661
KINEPRAKTIJK VANDEKERKHOF CHRIS
BE 0604.989.295
Peer · Eq €72,603
KINOST
BE 0480.185.335
Antwerpen · Eq €72,826
STUDIO COCO
BE 0684.755.068
Blankenberge · Eq €72,556
Of 12,699 companies in sector 86951 we hold annual accounts for 2,146. 1,930 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded01-01-1983
Fiscal year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID
0208:0423990364
Registered
30-07-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.